|
|
巨噬细胞迁移抑制因子与肿瘤相关的研究进展 |
肖经雪, 马婕 |
青海大学附属医院(临床医学院), 青海 西宁 810001 |
|
[1] Sparkes A,De Baetselier P,Roelants K,et al.The non-mammalian MIF superfamily[J].Immunobiology,2017,222(3):473-482. [2] Bloom BR,Bennett B.Mechanism of a reaction in vitroassociated with delayed-type hypersensitivity[J].Science,1966,153(3731):80-82. [3] Tanese K,Ogata D.The role of macrophage migration inhibitory factor family and CD74 in the pathogenesis of melanoma[J].Exp Dermatol.2024,33(6):15122. [4] Tilstam PV,Pantouris G,Corman M,et al.A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2),a MIF cytokine superfamily member,inhibits MIF-2 biological activity[J].Biol Chem,2019,294(49):18522-18531. [5] 张欢,杨辰,尚爽,等.不同亚细胞定位的巨噬细胞迁移抑制因子促肿瘤功能研究进展[J].药学学报,2023,58(8):2085-2097. [6] Osipyan A,Chen D,Dekker FJ.Epigenetic regulation in macrophage migration inhibitory factor (MIF)-mediated signaling in cancer and inflammation[J].Drug Discov Today,2021,26(7):1728-1734. [7] Valdez CN,Sánchez-Zuno GA,Bucala R,et al.Macrophage migration inhibitory factor (MIF) and D-dopachrome tautomerase (DDT):pathways to tumorigenesis and therapeutic opportunities[J] Int Mol Sci,2024,25(9):4849. [8] Safi W,Kraus A,Grampp S,et al.Macrophage migration inhibitory factor is regulated by HIF-1α and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner[J].Mol Med (Berl).2020,98(11):1547-1559. [9] Jankauskas SS,Wong DWL,Bucala R,et al.Evolving complexity of MIF signaling[J].Cell Signal,2019(57):76-88. [10] Klemke L,De Oliveira T,Witt D,et al.Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer[J].Cell Death Dis,2021,12(2):155. [11] Hu S,Feng J,Fu W,et al.Macrophage migration inhibitory factor (MIF) upregulates CXCR7 and contributes to chemotherapy resistance in colorectal cancer[J].Cell Biochem Biophys,2024,82(4):3437-3452. [12] Wirtz TH,Saal A,Bergmann I,et al.Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma[J].Br Pharmacol,2021,178(22):4452-4467. [13] Cao T,Sun Q,Shi X,et al.EAF2 downregulation recruits tumor-associated macrophages in prostate cancer through upregulation of MIF[J].Biol Proced Online,2024,26(1):21. [14] Spertini C,Benechet AP,Birch F,et al.Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia[J].Cell Death Discov,2024,10(1):157. [15] Abdul-Aziz AM,Shafat MS,Sun Y,et al.HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia[J].Oncogene,2018,37(20):2676-2686. [16] Wang Q,Zhao D,Xian M,et al.MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma[J].Blood,2020,136(22):2557-2573. [17] Talos F,Mena P,Fingerle-Rowson G,et al.MIF loss impairs myc-induced lymphomagenesis[J].Cell Death Differ,2005,12(10):1319-1328. [18] Jeong H,Lee SY,Seo H,et al.Recombinant mycobacterium smegmatis delivering a fusion protein of human macrophage migration inhibitory factor (MIF) and IL-7 exerts an anticancer effect by inducing an immune response against MIF in a tumor-bearing mouse model[J].Immunother Cancer,2021,9(8):3180. [19] Jia X,Xi J,Tian B,Zhang Y,et al.The tautomerase activity of tumor exosomal MIF promotes pancreatic cancer progression by modulating MDSC differentiation[J].Cancer Immunol Res,2024,12(1):72-90. [20] Yang M,Wu S,Cai W,et al.Hypoxia-induced MIF induces dysregulation of lipid metabolism in Hep2 laryngocarcinoma through the IL-6/JAK-STAT pathway[J].Lipids Health Dis,2022,21(1):82. [21] Mawhinney L,Armstrong ME,O' Reilly C,et al.Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer[J].Mol Med,2015,20(1):729-735. [22] Ioannou K,Cheng KF,Crichlow GV,et al.ISO-66,a novel inhibitor of macrophage migration,shows efficacy in melanoma and colon cancer models[J].Int Oncol,2014,45(4):1457-1468. [23] Lee SH,Kwon HJ,Park S,et al.Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme[J].PLoS One,2021,16(9):257375. [24] Valdez CN,Sanchez-Zuno GA,Bucala R,wt al.Macrophage migration inhibitory factor (MIF) and D-dopachrome tautomerase (DDT):pathways to tumorigenesis and therapeutic opportunities[J].Int Mol Sci,2024,25 (9):4849. |
[1] |
王羊洋, 倪刚, 金吴娟, 余菲, 裴翀. 病原体靶向测序技术在持续性炎性反应-免疫抑制-分解代谢综合征老年患者中的诊疗价值[J]. 河北医学, 2025, 31(5): 743-748. |
[2] |
谭粤, 姚粝芹, 穆文博. 髓源性抑制细胞在细菌感染中的研究进展[J]. 河北医学, 2024, 30(11): 1928-1933. |
[3] |
梁霜, 张蕾, 宋卿. m6A甲基化修饰对大肠癌转移的影响以及中医药干预机制研究[J]. 河北医学, 2023, 29(12): 2109-2112. |
[4] |
万微波, 卢蓉, 熊蓉, 汪超阳, 范学朋, 胡述立. 双重血浆置换联合免疫抑制剂治疗重症狼疮性肾炎疗效及对外周血Alb BUN WBC水平的影响[J]. 河北医学, 2022, 28(1): 61-65. |
[5] |
梁志强, 姜凤云, 赵蕾, 王雪燕, 常晓华, 刘艳伶, 王亚婷. 皮肌炎相关的肺间质病变经激素联合免疫抑制剂治疗后肺功能变化[J]. 河北医学, 2016, 22(10): 1600-1601. |
|
|
|
|